Fever in the Toddler-Aged Child: Old Concerns Replaced With New Ones

Clinical Pediatric Emergency Medicine

Volumn 9, Issue 4, 2008, Pages 221-227

  Mahajan, Prashant ^a   Stanley, Rachel ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

bacteremia; emergency medicine; fever; toddler

Indexed keywords

ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CHILD; DRUG EFFICACY; DRUG SAFETY; FEVER; FOLLOW UP; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION PREVENTION; INFLUENZA; MEDICAL ASSESSMENT; NONHUMAN; PNEUMONIA; PRACTICE GUIDELINE; SCREENING; SENSITIVITY AND SPECIFICITY; SEROTYPE; STREPTOCOCCUS INFECTION; TODDLER; URINARY TRACT INFECTION; VACCINATION;

EID: 56349149674     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpem.2008.09.003     Document Type: Article

References (52)

1. McCaig L.F., and Nawar E.N. National hospital ambulatory medical care survey: 2004 emergency department summary. Adv Data 23 (2006) 1-29
2. Baraff L.J., Bass J.W., Fleisher G.R., et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Ann Emerg Med 22 (1993) 1198-1210
3. Lee G.M., Fleisher G.R., and Harper M.B. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics 108 (2001) 835-844
4. Kupperman N. The evaluation of young febrile children for occult bacteremia-time to revaluate our approach. Arch Pediatr Adolesc Med 156 (2002) 855-857
5. Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 57 (2008) 144-148
6. Byington C.L., Samore M.H., Stoddard G.J., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41 (2005) 21-29
7. McGee L. The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae. Curr Opin Microbiol 10 (2007) 473-478
8. Steenhof A.P., Shah S.S., Ratner A.J., et al. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin Infect Dis 42 (2006) 907-914
9. Trophy D.E., and Ray C.G. Occult pneumococcal bacteremia. Am J Dis Child 119 (1970) 12-17
10. Jaffe D.M., Tanz R.R., Davis A.T., et al. Antibiotic administration to treat possible occult bacteremia in febrile children. N Engl J Med 317 (1987) 1175-1180
11. Bass J.W., Steele R.W., Witler R.R., et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J 12 (1993) 466-473
12. Centers for Disease Control and Prevention. Progress towards elimination of Haemophilus influenzae type b disease among infants and children-United States. 1987-1995. MMWR Morb Mortal Wkly Rep 45 (1996) 901-906
13. Lee G.M., and Harper M.B. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 152 (1998) 624-628
14. Alpern E.R., Alessandrini E.A., McGowan K.L., et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 106 (2000) 505-511
15. Myers C., and Gervaix A. Streptococcus pneumoniae bacteraemia in children. Int J Antimicrob Agents 30 Suppl 1 (2007) S24-S28
16. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49 RR-9 (2000) 1-35
17. Kuppermann N., Fleisher G., and Jaffe D. Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med 31 (1998) 679-687
18. Harper M.B., Bachur R., and Fleisher G.R. Effect of antibiotic therapy on the outcome of outpatients with unsuspected bacteremia. Pediatr Infect Dis J 14 (1995) 760-767
19. Kuppermann N., Malley R., Inkelis S.H., et al. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics 103 (1999) E20
20. Finkelstein J.A., Christiansen C.L., and Platt R. Fever in pediatric primary care: occurrence, management, and outcomes. Pediatrics 105 1 Pt 3 (2000) 260-266
21. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19 (2000) 187-195
22. Black S., Shinefield H., Baxter R., et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 23 (2004) 485-489
23. Stoll M.L., and Rubin L.G. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med 158 (2004) 671-675
24. Herz A.M., Greenhow T.L., Alcantara J., et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 25 (2006) 293-300
25. Sard B., Bailey M.C., and Vinci R. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department. Pediatr Emerg Care 22 (2006) 295-300
26. Carstairs K.L., Tanen D.A., Johnson A.S., et al. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. Ann Emerg Med 49 (2007) 772-777
27. Klein J. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization. Pediatr Infect Dis J 21 (2002) 584-588
28. ACEP Clinical Policies Committee and the Clinical Policies Committee and the Clinical Policies Subcommittee on Pediatric Fever. Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 42 (2003) 530-545
29. Bachur R., Perry H., and Harper M.B. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 33 (1999) 166-173
30. Zhou F., Kyaw M.H., Shefer A., et al. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med 161 (2007) 1162-1168
31. Murphy C.G., van de Pol A.C., Harper M.B., et al. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med 14 (2007) 243-249
32. Tsai C.J., Griffin M.R., Pekka Nuorti J., et al. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 46 (2008) 1664-1672
33. Shaikh N., Morone N.E., Lopez J., et al. Does this child have a urinary tract infection?. JAMA 298 (2007) 2895-2904
34. Baraff L.J. Management of fever without source in infants and children. Ann Emerg Med 36 (2000) 602-614
35. Gabriel M.E., Aiuto L., Kohn N., et al. Management of febrile children in the conjugate pneumococcal vaccine era. Clin Pediatr (Phila) 43 (2004) 75-82
36. Nigrovic L.E., and Malley R. Evaluation of the febrile child 3 to 36 months old in the era of pneumococcal conjugate vaccine: focus on occult bacteremia. Clin Pediatr Emerg Med 5 (2004) 13-19
37. Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for fever of uncertain source in children in 2 to 36 months of age (2003), Cincinnati Children's Hospital Medical Center, Cincinnati (Oh). Oct 27. Available at: www.guideline.gov Accessed on 06/18/08
38. Kaplan S.L., Mason Jr. E.O., Wald E.R., et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113 3 Pt 1 (2004) 443-449
39. Singleton R.J., Hennessy T.W., Bulkow L.R., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 (2007) 1784-1792
40. Gonzalez B.E., Hulten K.G., Lamberth L., et al. and the U.S. Pediatric Multicenter Pneumococcal Surveillance Group. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 25 (2006) 301-305
41. Long S. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine. Clin Infect Dis 41 (2005) 30-34
42. Schultz K.D., Fan L.L., Pinsky J., et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113 (2004) 1735-1740
43. Tan T.Q., Mason Jr. E.O., Wald E.R., et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110 1 Pt 1 (2002) 1-6
44. Hsiao A.L., and Baker M.D. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr 17 (2005) 56-61
45. Zaidi E., Bachur R., and Harper M. Non-typhi Salmonella bacteremia in children. Pediatr Infect Dis J 181 (1999) 1073-1077
46. Cummings C.A., and Relman D.A. Genomics and microbiology. Microbial forensics: "cross-examining pathogens". Science 296 (2002) 1976-1979
47. Relman D.A. The human body as microbial observatory. Nat Genet 30 (2002) 131-133
48. Thuler L.C., Jenicek M., Turgeon J.P., et al. Impact of a false positive blood culture result on the management of febrile children. Pediatr Infect Dis J 16 (1997) 846-851
49. Yamamoto L.G. Revising the decision analysis for febrile children at risk for occult bacteremia in a future era of widespread pneumococcal immunization. Clin Pediatr (Phila) 40 (2001) 583-594
50. Sharma V., Dowd M.D., Slaughter A.J., et al. Effect of rapid diagnosis of influenza virus type A on the emergency department management of febrile infants and toddlers. Arch Pediatr Adolesc Med 156 (2002) 41-43
51. Bonner A.B., Monroe K.W., Talley L.I., et al. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 112 (2003) 363-367
52. Smitherman H.F., Caviness A.C., and Macias C.G. Retrospective review of serious bacterial infections in infants who are 0 to 36 months and have influenza A infection. Pediatrics 115 (2005) 710-718